Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-06-06
2006-06-06
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S168000
Reexamination Certificate
active
07056931
ABSTRACT:
The current invention provides novel 2-substituted 1,2,3,4-tetrahydroquinolin-6-ols and derivatives thereof of the formula (I) (A); pharmaceutical compositions thereof, optionally in combination with estrogen or progestin; methods for inhibiting a disease associated with estrogen deprivation; and methods for inhibiting a disease associated with an aberrant physiological response to endogenous estrogen.
REFERENCES:
patent: 3819637 (1974-06-01), Bell
patent: 3994902 (1976-11-01), Bell
patent: 4075227 (1978-02-01), Jones et al.
patent: 4133814 (1979-01-01), Jones et al.
patent: 4230862 (1980-10-01), Suarez et al.
patent: 4418068 (1983-11-01), Jones
patent: 5393763 (1995-02-01), Black et al.
patent: 5403847 (1995-04-01), Gluchowski et al.
patent: 5446053 (1995-08-01), Keohane
patent: 5457116 (1995-10-01), Black et al.
patent: 5461065 (1995-10-01), Black et al.
patent: 5482949 (1996-01-01), Black et al.
patent: 5508306 (1996-04-01), Chiu et al.
patent: 5510357 (1996-04-01), Palkowitz
patent: 5523309 (1996-06-01), Bryant et al.
patent: 5567828 (1996-10-01), Dodge
patent: 5686465 (1997-11-01), Merand et al.
patent: 5688796 (1997-11-01), Cullinan et al.
patent: 5723474 (1998-03-01), Palkowitz
patent: 5726168 (1998-03-01), Cullinan et al.
patent: 5728724 (1998-03-01), Bryant et al.
patent: 5811421 (1998-09-01), Dodge et al.
patent: 5840735 (1998-11-01), Labrie et al.
patent: 5843963 (1998-12-01), Hauser et al.
patent: 5843965 (1998-12-01), Palkowitz
patent: 5916916 (1999-06-01), Hauser et al.
patent: 5929090 (1999-07-01), Hauser et al.
patent: 5948795 (1999-09-01), Berg et al.
patent: 5948796 (1999-09-01), Bryant et al.
patent: 5958916 (1999-09-01), Bryant et al.
patent: 5958969 (1999-09-01), Bryant et al.
patent: 5962475 (1999-10-01), Schmid et al.
patent: 5981570 (1999-11-01), Bryant et al.
patent: 5985897 (1999-11-01), Muehl et al.
patent: 5998401 (1999-12-01), Palkowitz
patent: 5998442 (1999-12-01), Yong Cho et al.
patent: 6017914 (2000-01-01), Bryant et al.
patent: 6025382 (2000-02-01), Bastian et al.
patent: 6060488 (2000-05-01), Dodge et al.
patent: 6090843 (2000-07-01), Bryant et al.
patent: 6303634 (2001-10-01), Cohen et al.
patent: 6384053 (2002-05-01), Muehl
patent: 6391892 (2002-05-01), Bryant et al.
patent: 6395755 (2002-05-01), Bryant et al.
patent: 6399634 (2002-06-01), Bryant et al.
patent: 6410564 (2002-06-01), Bryant et al.
patent: 6417199 (2002-07-01), Muehl
patent: 6432982 (2002-08-01), Cullinan et al.
patent: 6432983 (2002-08-01), Cullinan et al.
patent: 6440958 (2002-08-01), Jones et al.
patent: 6444688 (2002-09-01), Dodge et al.
patent: 6479517 (2002-11-01), Bryant et al.
patent: 6509356 (2003-01-01), Dodge et al.
patent: 6599920 (2003-07-01), Bryant et al.
patent: 6608090 (2003-08-01), Bourgeois et al.
patent: 113007 (1984-07-01), None
patent: 0 773 217 (1997-05-01), None
patent: 0 802 183 (1997-10-01), None
patent: 0 802 184 (1997-10-01), None
patent: 0 835 867 (1998-04-01), None
patent: 0 747 380 (1998-09-01), None
patent: 0 729 951 (1999-06-01), None
patent: 1 113 007 (2001-04-01), None
patent: 04 316557 (1992-11-01), None
patent: WO 95/10513 (1995-04-01), None
patent: WO 95/17382 (1995-06-01), None
patent: WO 96/32937 (1996-10-01), None
patent: WO 97/25033 (1997-07-01), None
patent: WO 98 08797 (1998-03-01), None
patent: WO 98/48793 (1998-11-01), None
patent: WO 99/19293 (1999-04-01), None
patent: WO 99/59969 (1999-11-01), None
XP002170868; “Structure-Activity-Relationship of Antiestrogens. Effect of the Side Chain and Its Position on the Activity of 2,3-Diaryl-2H-1-Benzopyrans”; Sharma, A.P., et al; Journal of Medicinal Chemistry, American Chemical Society, Washington, U.S.; vol. 33; 1990; pp. 3216-3222.
XP002211488; “New 1,2,3,4-tetrahydroquinoline-carboxylic acid Derivatives”; Derwent Publications, Ltd., London, GB; AN 1992-420416.
Demeter John C.
Eli Lilly and Company
Grazier Nyeemah
Solola Taofiq
LandOfFree
2-substituted 1,2,3,4-tetrahydroquinolines and derivatives... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3651553